Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging (VREX) has 11 years of Cash & Equivalents data on file, last reported at $85.3 million in Q2 2026.

• Quarterly Cash & Equivalents fell 58.41% year-over-year to $85.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $85.3 million (down 58.41% YoY) and the FY2025 annual result came in at $145.0 million, down 14.05% from the prior year.
• Cash & Equivalents eased to $85.3 million in Q2 2026 per VREX's latest filing, from $119.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $205.1 million in Q2 2025 and bottomed at $81.5 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $136.4 million (2025), against an average of $131.6 million.
• The widest annual swing landed in 2023, when Cash & Equivalents soared 73.37%; it then tumbled 58.41% in 2026.
• Tracing VREX's Cash & Equivalents over 5 years: stood at $81.5 million in 2022, then soared by 73.37% to $141.3 million in 2023, then advanced by 19.39% to $168.7 million in 2024, then decreased by 14.05% to $145.0 million in 2025, then slumped by 41.17% to $85.3 million in 2026.
• Per Business Quant, the three latest VREX Cash & Equivalents figures stand at $85.3 million (Q2 2026), $119.5 million (Q1 2026), and $145.0 million (Q4 2025).

Peer Comparison